To enhance the effectiveness of GLP-1 RAs in managing pediatric obesity, we propose a comprehensive clinical medication use management process that includes review, screening, combination therapy, education, monitoring, and follow-up
American Psychiatric Association: Washington, DC, 1994
Across the trials, when people stop the medication, the weight tends to come back, on the order of two-thirds of what was lost within a year
More research is needed to fully understand how GLP-1 medications affect pregnancy and pregnancy planning, so using reliable contraception while taking this type of medication is suggested (2)
This combo supports: We help you figure out whether stacking peptides makes sense based on your goals, and we make sure its done safely